Debra Richardson to Tumor Microenvironment
This is a "connection" page, showing publications Debra Richardson has written about Tumor Microenvironment.
Connection Strength
0.050
-
A phase III, multicenter, randomized study of olvimulogene nanivacirepvec followed by platinum-doublet chemotherapy and bevacizumab compared with platinum-doublet chemotherapy and bevacizumab in women with platinum-resistant/refractory ovarian cancer. Int J Gynecol Cancer. 2023 09 04; 33(9):1458-1463.
Score: 0.050